The study, published in Nature Medicine, demonstrated that blood levels of MTBR-tau243 could accurately differentiate between patients with early and later stages
The study found that the most active participants—those who engaged in consistent, moderate activity—were 25% less likely to develop cancer compared to
TNBC presents a unique challenge for conventional therapies because it lacks the specific proteins that are targeted by many traditional treatments for
This study marks the first time researchers have demonstrated that gamma delta IELs are critical in balancing pro-inflammatory and regulatory immune responses